GB Sciences, Inc. (GBLX)
0.0003
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
GB Sciences Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2024 | -0.3392 |
| September 30, 2024 | -0.3234 |
| June 30, 2024 | -0.3148 |
| March 31, 2024 | -0.3311 |
| December 31, 2023 | -0.312 |
| September 30, 2023 | -0.32 |
| June 30, 2023 | -0.3068 |
| March 31, 2023 | -0.3168 |
| December 31, 2022 | -0.8657 |
| September 30, 2022 | -1.164 |
| June 30, 2022 | -0.6409 |
| March 31, 2022 | -0.7768 |
| December 31, 2021 | 1.022 |
| September 30, 2021 | -1.590 |
| June 30, 2021 | -1.933 |
| March 31, 2021 | -2.637 |
| December 31, 2020 | -1.607 |
| September 30, 2020 | -2.736 |
| June 30, 2020 | -6.157 |
| March 31, 2020 | -58.83 |
| December 31, 2019 | 1.069 |
| September 30, 2019 | 1.673 |
| June 30, 2019 | 1.629 |
| March 31, 2019 | 0.737 |
| December 31, 2018 | 0.7486 |
| Date | Value |
|---|---|
| September 30, 2018 | 0.5814 |
| June 30, 2018 | 0.5702 |
| March 31, 2018 | 0.5925 |
| December 31, 2017 | 0.8542 |
| September 30, 2017 | 0.891 |
| June 30, 2017 | 0.5402 |
| March 31, 2017 | 0.4719 |
| December 31, 2016 | 1.351 |
| September 30, 2016 | 3.234 |
| June 30, 2016 | -4.092 |
| March 31, 2016 | -1.378 |
| December 31, 2015 | -1.984 |
| September 30, 2015 | -3.957 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.0603 |
| December 31, 2014 | 0.0044 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.1367 |
| March 31, 2014 | -1.246 |
| December 31, 2013 | -0.5476 |
| September 30, 2013 | -0.5733 |
| June 30, 2013 | -0.5561 |
| March 31, 2013 | -0.5634 |
| December 31, 2012 | -0.6559 |
| September 30, 2012 | -0.6475 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Cocrystal Pharma, Inc. | 1.284 |
| CNBX Pharmaceuticals, Inc. | -0.4388 |
| Arvinas, Inc. | 0.0146 |
| Fulcrum Therapeutics, Inc. | 0.017 |
| Definium Therapeutics, Inc. | 0.0397 |